首页> 外文OA文献 >Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high‐risk follicular lymphoma: CALGB 50904 (Alliance)

【2h】

Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high‐risk follicular lymphoma: CALGB 50904 (Alliance)

机译：在以前未经治疗的高风险卵泡淋巴瘤患者中的atumumab和bendamustine的随机试验，培斯汀，Bendamustine和bortezomib：calgb 50904（联盟）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kristie A. Blum; Mei‐Yin Polley; Sin‐Ho Jung; Travis J. Dockter; Sarah Anderson; Eric D. Hsi; Nina Wagner‐Johnston; Beth Christian; Jim Atkins; Bruce D. Cheson; John P. Leonard; Nancy L. Bartlett;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high‐risk follicular lymphoma: CALGB 50904 (Alliance) [J] . Blum Kristie A., Polley Mei‐Yin, Jung Sin‐Ho, Cancer: A Journal of the American Cancer Society . 2019,第19期

机译：在先前未经治疗的高风险卵泡淋巴瘤患者中的atumumab和bendamustine与atumumab，bendamustine和bortezomib的随机试验：calgb 50904（联盟）
2. Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance) [J] . Leonard John P., Jung Sin-Ho, Johnson Jeffrey, Journal of Clinical Oncology . 2015,第31期

机译：来那度胺与来那度胺加利妥昔单抗治疗复发性滤泡性淋巴瘤的随机对照试验：CALGB 50401（联盟）
3. Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance) [J] . Leonard John P., Jung Sin-Ho, Johnson Jeffrey, Journal of Clinical Oncology . 2015,第31期

机译：单独的Lenalidomide对Lenalidomide Plus Rituximab的随机试验在复发性滤泡淋巴瘤患者中：CalgB 50401（联盟）
4. RISK-ADAPTED INTRAVENOUS MELPHALAN WITH ADJUVANT THALIDOMIDE AND DEXAMETHASONE FOR NEWLY DIAGNOSED UNTREATED PATIENTS WITH SYSTEMIC AL AMYLOIDOSIS: INTERIM REPORT OF A PHASE II TRIAL [C] . RL Comenzo, P Zhou, L Reich, International Symposium on Amyloidosis . 2005

机译：风险适应的静脉内莫尔甘蔗用佐剂沙利度胺和地塞米松，用于新诊断的未经治疗的全身淀粉样蛋白症患者：II期试验的中期报告
5. Hypotensive resuscitation versus standard fluid resuscitation for the management of trauma patients in hemorrhagic shock: The safety phase of a randomized controlled trial. [D] . Morrison, C. Anne. 2009

机译：低血压复苏与标准液体复苏在失血性休克中对创伤患者的处理：一项随机对照试验的安全性阶段。
6. Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance) [O] . John P. Leonard, Sin-Ho Jung, Jeffrey Johnson, -1

机译：来那度胺与来那度胺加利妥昔单抗治疗复发性滤泡性淋巴瘤的随机对照试验：CALGB 50401（联盟）
7. Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance) [O] . John P. Leonard, Sin-Ho Jung, Jeffrey Johnson, 2015

机译：单独的Lenalidomide对Lenalidomide Plus Rituximab的随机试验在复发性滤泡淋巴瘤患者中：CalgB 50401（联盟）

Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high‐risk follicular lymphoma: CALGB 50904 (Alliance)

著录项

引文网络

相似文献

相关主题

期刊订阅